Show simple item record

dc.contributor.authorAtkin, J
dc.contributor.authorHalova, L
dc.contributor.authorFerguson, J
dc.contributor.authorHitchin, James R
dc.contributor.authorLichawska-Cieslar, A
dc.contributor.authorJordan, Allan M
dc.contributor.authorPines, J
dc.contributor.authorWellbrock, C
dc.contributor.authorPetersen, J
dc.date.accessioned2014-07-08T15:00:14Z
dc.date.available2014-07-08T15:00:14Z
dc.date.issued2014-03-15
dc.identifier.citationTorin1-mediated TOR kinase inhibition reduces Wee1 levels and advances mitotic commitment in fission yeast and HeLa cells. 2014, 127 (Pt 6):1346-56 J Cell Scien
dc.identifier.issn1477-9137
dc.identifier.pmid24424027
dc.identifier.doi10.1242/jcs.146373
dc.identifier.urihttp://hdl.handle.net/10541/322632
dc.description.abstractThe target of rapamycin (TOR) kinase regulates cell growth and division. Rapamycin only inhibits a subset of TOR activities. Here we show that in contrast to the mild impact of rapamycin on cell division, blocking the catalytic site of TOR with the Torin1 inhibitor completely arrests growth without cell death in Schizosaccharomyces pombe. A mutation of the Tor2 glycine residue (G2040D) that lies adjacent to the key Torin-interacting tryptophan provides Torin1 resistance, confirming the specificity of Torin1 for TOR. Using this mutation, we show that Torin1 advanced mitotic onset before inducing growth arrest. In contrast to TOR inhibition with rapamycin, regulation by either Wee1 or Cdc25 was sufficient for this Torin1-induced advanced mitosis. Torin1 promoted a Polo and Cdr2 kinase-controlled drop in Wee1 levels. Experiments in human cell lines recapitulated these yeast observations: mammalian TOR (mTOR) was inhibited by Torin1, Wee1 levels declined and mitotic commitment was advanced in HeLa cells. Thus, the regulation of the mitotic inhibitor Wee1 by TOR signalling is a conserved mechanism that helps to couple cell cycle and growth controls.
dc.language.isoenen
dc.rightsArchived with thanks to Journal of cell scienceen
dc.titleTorin1-mediated TOR kinase inhibition reduces Wee1 levels and advances mitotic commitment in fission yeast and HeLa cells.en
dc.typeArticleen
dc.contributor.departmentFaculty of Life Sciences, University of Manchester, Michael Smith Building, Manchester M13 9PT, UK.en
dc.identifier.journalJournal of Cell Scienceen
html.description.abstractThe target of rapamycin (TOR) kinase regulates cell growth and division. Rapamycin only inhibits a subset of TOR activities. Here we show that in contrast to the mild impact of rapamycin on cell division, blocking the catalytic site of TOR with the Torin1 inhibitor completely arrests growth without cell death in Schizosaccharomyces pombe. A mutation of the Tor2 glycine residue (G2040D) that lies adjacent to the key Torin-interacting tryptophan provides Torin1 resistance, confirming the specificity of Torin1 for TOR. Using this mutation, we show that Torin1 advanced mitotic onset before inducing growth arrest. In contrast to TOR inhibition with rapamycin, regulation by either Wee1 or Cdc25 was sufficient for this Torin1-induced advanced mitosis. Torin1 promoted a Polo and Cdr2 kinase-controlled drop in Wee1 levels. Experiments in human cell lines recapitulated these yeast observations: mammalian TOR (mTOR) was inhibited by Torin1, Wee1 levels declined and mitotic commitment was advanced in HeLa cells. Thus, the regulation of the mitotic inhibitor Wee1 by TOR signalling is a conserved mechanism that helps to couple cell cycle and growth controls.


This item appears in the following Collection(s)

Show simple item record